Tatsuhiko Kashii - Concepedia

Author

Tatsuhiko Kashii

Tohoku Medical and Pharmaceutical University

Also Known As

T KASHII, T Kashii, T. KASHII, T. Kashii, TATSUHIKO KASHII, Tatsuhiko KASHII, Tatsuhiko Kashii

116

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

Tohoku Medical and Pharmaceutical University Toyama University Hospital University of Toyama Kouseiren Takaoka Hospital Kindai University

About

Tatsuhiko Kashii is an author at Tohoku Medical and Pharmaceutical University specializing in medicine, lung cancer, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	16	735
2	Health Sciences	4	4	100
3	Natural Sciences	2	2	52
4	Biochemistry	2	2	52
5	Allergy	1	1	144

Tatsuhiko Kashii

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Multicentre prospective phase II trial of gefitinib for advanced non-small cell lung cancer with epidermal growth factor receptor mutations: results of the West Japan Thoracic Oncology Group trial (WJTOG0403) Kenji Tamura, Isamu Okamoto, Tatsuhiko Kashii, British Journal of Cancer	2008	203
Randomized Phase III Trial of Platinum-Doublet Chemotherapy Followed by Gefitinib Compared With Continued Platinum-Doublet Chemotherapy in Japanese Patients With Advanced Non–Small-Cell Lung Cancer: Results of a West Japan Thoracic Oncology Group Trial (WJTOG0203) Koji Takeda, Toyoaki Hida, Tosiya Sato, Journal of Clinical Oncology	2009	170
Leukotriene C4 synthase promoter polymorphism in Japanese patients with aspirin-induced asthma Yukio Kawagishi, Haruhisa Mita, Masami Taniguchi, Journal of Allergy and Clinical Immunology InflammationAsthmaInflammatory Lung DiseaseAllergyMedicine	2002	144
Bradykinin stimulates IL-6 and IL-8 production by human lung fibroblasts through ERK- and p38 MAPK-dependent mechanisms Ryuji Hayashi, Naohiro Yamashita, Shoko Matsui, European Respiratory Journal Inflammatory Lung DiseaseLung InflammationIl-8 ProductionImmunologyPathology	2000	101
Survival and Prognosis After Pneumonectomy for Lung Cancer in the Elderly Yutaka Mizushima, Hirofumi Noto, Shigeki Sugiyama, The Annals of Thoracic Surgery Surgical OncologyAdvanced Lung DiseaseGeriatricsMedicineCancer Management	1997	94
Ionizing radiation enhances matrix metalloproteinase-2 production in human lung epithelial cells Jun Araya, Muneharu Maruyama, K Sassa, American Journal of Physiology-Lung Cellular and Molecular Physiology Acute Lung InjuryRadiation EnhancesInflammatory Lung DiseaseMetalloproteinase-2 ProductionLung Inflammation	2001	69
EGFR Mutation of Tumor and Serum in Gefitinib-Treated Patients with Chemotherapy-Naive Non–small Cell Lung Cancer Hideharu Kimura, Kazuo Kasahara, Kazuhiko Shibata, Journal of Thoracic Oncology MedicinePathologyCancer TreatmentCancer GeneticsOncology	2006	68
Randomized phase III study of platinum-doublet chemotherapy followed by gefitinib versus continued platinum-doublet chemotherapy in patients (pts) with advanced non-small cell lung cancer (NSCLC): Results of West Japan Thoracic Oncology Group trial (WJTOG Toyoaki Hida, Isamu Okamoto, Tatsuhiko Kashii, Journal of Clinical Oncology PharmacotherapyOncologyMetronomic TherapyClinical TrialsRadiation Oncology	2008	54
Utility of creatinine/cystatin C ratio as a predictive marker for adverse effects of chemotherapy in lung cancer: A retrospective study Kensuke Suzuki, Hideaki Furuse, Takeshi Tsuda, Journal of International Medical Research	2015	52
Hydrogen Peroxide Induces Upregulation of Fas in Human Airway Epithelial Cells via the Activation of PARP-p53 Pathway Tadashi Fujita, Muneharu Maruyama, Jun Araya, American Journal of Respiratory Cell and Molecular Biology Lung InflammationLipid PeroxidationApoptosisCell DeathCell Death Mechanisms	2002	40

Page 1